Efficacy and Safety of Low-dose Ticagrelor

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3043 participants.

Also called NCT03381742

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 3,043 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03381742
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03381742. Non-randomized; single masking; primary purpose treatment. Start 2017-12-13 (actual); primary completion 2018-12-13 (actual). Results posted on 2019-09-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Low-dose Ticagrelor
Intervention (Drug)
Ticagrelor
Intervention (Drug)
ticagrelor
Intervention (Drug)
ticagrelor
Intervention (Drug)
clopidogrel
Lead sponsor
First Affiliated Hospital of Harbin Medical University (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)
Collaborator
The First Affiliated Hospital of Dalian Medical University (class: other)
Collaborator
The Central Hospital of Jia Mu Si City (class: not stated)
Collaborator
First Affiliated Hospital of Kunming Medical University (class: other)
Collaborator
RenJi Hospital (class: other)
Collaborator
Tianjin Medical University General Hospital (class: other)
Collaborator
Weifang People's Hospital (class: other)
Collaborator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)
Collaborator
Shengjing Hospital (class: other)
Collaborator
Shaanxi Provincial People's Hospital (class: other)

Record details

Record id
cardio:ct-nct03381742
Content hash
48b89634a75597f13c56d3f16a7014be960d9d02168c1f8587e309fb99fb3e20